Results 51 to 60 of about 10,822,828 (202)

Central Giant Cell Granuloma of the mandibular condyle – Endoscopic treatment and 5-year follow-up

open access: yesAdvances in Oral and Maxillofacial Surgery, 2021
Central Giant Cell Granuloma reported in the mandibular condyle. An endoscopic approach with enucleation and peripheral ostectomy resulted in minimal cosmetic and functional changes to the patient.
William A. Grosdidier   +3 more
doaj   +1 more source

Nail Toxicities Associated With Anticancer Therapies in Children

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Nail toxicities are a frequent yet often underrecognized component of dermatologic adverse events in children receiving anticancer therapies. Both conventional cytotoxic chemotherapy and newer targeted agents can affect the nail matrix, nail bed and periungual tissues, producing a broad spectrum of clinical manifestations that range from ...
Luca Rapparini, Michela Starace
wiley   +1 more source

Estudo clínico-patológico de lesões centrais e periféricas de células gigantes da cavidade bucal [PDF]

open access: yes, 2015
TCC (graduação) - Universidade Federal de Santa Catarina. Centro de Ciências da Saúde. Odontologia.Como as lesões periféricas (LPCG) e principalmente as lesões centrais de células gigantes (LCCG) podem mimetizar clínica e radiograficamente lesões ...
Lopes, Mariana Réos
core  

The Comparison of Clinical Behaviour of Peripheral and Central Giant Cell Granuloma by Immunohistochemistry

open access: yes, 2021
Peripheral giant cell granuloma (PGCG) and central giant cell granuloma (CGCG) of the jaws are benign proliferations of mononucleated cells (MCs) and multinucleated giant cells (MGCs).
Aksakallı, Fatma Nihan   +3 more
core   +1 more source

Central giant cell granuloma of the maxila [PDF]

open access: yes, 2003
Se presenta un caso de granuloma central de células gigantes en un paciente de 20 años de edad localizado en maxilar superior, con características histológicas indistinguibles del tumor de células gigantes.
Manuel María Romero Ruíz   +4 more
core   +1 more source

Peripheral Giant Cell Granuloma

open access: yes, 2021
Objective: Peripheral giant cell granuloma is a well-defined pathologic entity which occurs at dentate and indentatepatients. Peripheral giant cell granuloma is high recurrence rate and requires close monitoring after the treatment.Case descriptions: 85 ...
Karabiyik, Zülfikar   +2 more
core   +1 more source

Histone 3 Hyperacetylation and the Aggressive Behavior of Giant Cell Lesions

open access: yesCancer Medicine
Introduction Giant Cell Lesions exhibit variable aggressive clinical behavior. Understanding the molecular mechanisms of these lesions can facilitate a more personalized and effective therapeutic approach.
Caio César daSilva Barros   +4 more
doaj   +1 more source

Mycobacterium intracellulare M.i.198—A Promising Strain for Studying Pathogenesis of Nontuberculous Mycobacterial Pulmonary Disease (NTM‐PD)

open access: yesMicrobiology and Immunology, EarlyView.
ABSTRACT In this review, we introduce a promising strain for studying pathogenesis of nontuberculous mycobacterial pulmonary disease (NTM‐PD), Mycobacterium intracellulare M.i.198. M.i.198 was isolated from a patient with progressive Mycobacterium avium‐intracellulare complex pulmonary disease (MAC‐PD) in whom surgical operation was required to ...
Yoshitaka Tateishi   +3 more
wiley   +1 more source

Evaluation of the relationship between the expression of AgNOR and Ki67 with the recurrence rate in central granulomatous giant cell lesions: A case‐control

open access: yesClinical and Experimental Dental Research
Objectives Giant cell granuloma is a local nonneoplastic lesion that is divided into two categories, based on its site of occurrence: Central and peripheral giant cell granuloma.
Mina T. B. Dareh   +2 more
doaj   +1 more source

Cardiovascular toxicity from immune checkpoint inhibitor therapy: an inflammatory continuum

open access: yesBritish Journal of Pharmacology, EarlyView.
Immune checkpoint inhibitor (ICI) therapy has markedly improved outcomes in advanced malignancies but has also revealed a distinct spectrum of cardiovascular immune‐related adverse events. Myocarditis represents the most severe manifestation, while non‐inflammatory left ventricular dysfunction and vascular inflammation have emerged as additional ...
Fabrice Reyes   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy